NTGN News and Press, Neon Therapeutics Inc. From 01/28/20

Acadia Healthcare (NASDAQ: ACHC ) resumed with Equal Weight rating and $36 (11% upside) price target at Stephens. More news on: Acadia Healthcare Company, Inc., BioMarin Pharmaceutical Inc., Blueprint Medicines Corporation, Healthcare stocks news, Stocks on the move, , Read more ...

NEW YORK , Jan. 23, 2020 /PRNewswire/ -- Moore Kuehn, PLLC, a securities law firm located on Wall Street in downtown New York City , is investigating potential claims concerning whether the following proposed mergers are fair to shareholders.  Moore Kuehn may ultimately seek in...

BioNTech ( BNTX ) recently announced that it had acquired Neon Therapeutics ( NTGN ) for $67 million in an all-stock deal. The acquisition of this biotech was a wise one, because personalized antigens (neoantigens) can potentially become a more profound way of treating cancer patients....

NEW YORK, Jan. 20, 2020 (GLOBE NEWSWIRE) -- Halper Sadeh LLP, a global investor rights law firm, continues to investigate the following companies: Tech Data Corporation (NASDAQ: TECD) The investigation concerns whether Tech Data and its board of directors violated the federal securitie...

Gainers: Neon Therapeutics (NASDAQ: NTGN )  +44% . More news on: Neon Therapeutics, Inc., NantKwest, Inc., Signet Jewelers Limited, Stocks on the move, , Read more ...

Neon Therapeutics (NASDAQ: NTGN ) +62%  on being acquired  by BioNTech. More news on: Neon Therapeutics, Inc., Cemtrex, Inc., Signet Jewelers Limited, Stocks on the move, , Read more ...

Further expands BioNTech’s growing CAR-T and TCR therapy pipeline through addition of neoantigen specific cell therapies, including a T cell therapy targeting shared RAS oncogenes Accelerates BioNTech’s global expansion by creating a U.S. hub for research and clinical de...

Neon Therapeutics (NASDAQ: NTGN ) has filed a Clinical Trial Authorization (CTA) with the Dutch Health Authority for the evaluation of NEO-PTC-01 in patients with metastatic melanoma who are refractory to checkpoint inhibitors. More news on: Neon Therapeutics, Inc., Healthcare stocks new...

CAMBRIDGE, Mass., Dec. 18, 2019 (GLOBE NEWSWIRE) -- Neon Therapeutics, Inc. (Nasdaq: NTGN) today announced that it has filed a Clinical Trial Authorization (CTA) with the Dutch Health Authority for the evaluation of NEO-PTC-01 in patients with metastatic melanoma who are refractory to ...

Are Any Of These Penny Stocks On Your Watch List This Month? This week we saw something pivotal in the U.S. economy that could set the tone for 2020. Wednesday saw Federal Reserve Chairman Jerome Powell said the central bank’s attempt to ease the financial markets was working. What ...